Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

Clinical trial NCT01075880 · COMPLETED

Trial details

NCT number: NCT01075880
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2009-05-01
Primary completion: 2013-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.